You can view the research column published every month by SMC Laboratories.
2025.02.03
The STAM model as a model of liver fibrosis
Today, we present the comparison table on fibrosis models of the liver. Liver fibrosis is defined as ex…
READ MORE
2025.02.03
Silica-induced pulmonary fibrosis model
We would like to introduce you to a Silica-induced pulmonary fibrosis model. This model is suitable for you if…
READ MORE
2025.02.03
In Vitro Assay Service for Fibrosis Evaluation
We are delighted to announce the launch of our new in vitro assay service for fibrosis evaluation. &nbs…
READ MORE
2025.02.03
STAM mouse | Adiponectin-derived peptide study to inhibit MASH and fibrosis progression
Today, we would like to introduce an example of a proof-of-concept study of adiponectin-derived peptide ALY688…
READ MORE
2025.02.03
Lung functional marker in IPF model
We would like to introduce a non-invasive biomarkers for Idiopathic Pulmonary Fibrosis (IPF) disease models. &…
READ MORE
2025.02.03
Drug efficacy studies in NASH mouse model
Today, we would like to introduce a paper published by our client using our non-alcoholic steatohepatitis (NAS…
READ MORE
2025.02.03
Preclinical studies for IBD research: DSS model
We would like to introduce the dextran sulfate sodium (DSS) -induced colitis model, which is a clinically repr…
READ MORE
2025.02.03
Advantages of using multiple MASH models: STAM x GAN diet
Advantages of using multiple MASH models; STAMTM x GAN diet – Comprehensively covers criteria for…
READ MORE
2025.02.03
Expanding Our IPF Services: Introducing Male Mouse Models for Drug Efficacy Evaluation Studies
We would like to inform you that we have extended our drug efficacy evaluation study services for male bleomyc…
READ MORE
2025.02.03
The STAM Model in NASH fundamental research
We would like to share some examples of how our NASH-HCC model (STAMTM model) can be used for fundamental rese…
READ MORE
